Back to Journals » OncoTargets and Therapy » Volume 7

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era

Total article views   HTML views PDF downloads Totals
9,471 Dovepress* 8,541+ 1,404 9,945
PubMed Central* 930 363 1,293
Totals 9,471 1,767 11,238
*Since 8 August 2014
+Since July 2016

View citations on PubMed Central and Google Scholar